The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2024 | Liquid biopsy to diagnose CNS lymphoma and monitor treatment response
Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, discusses using liquid biopsy to improve diagnosis and monitoring of CNS lymphomas. This research focuses on using cerebrospinal fluid (CSF) or peripheral blood (PB) to detect microscopic disease levels that other methods might miss in order to diagnose disease and monitor treatment response. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
